Amgen Stock Performance

AMGN
 Stock
  

USD 283.29  1.62  0.57%   

On a scale of 0 to 100, Amgen holds a performance score of 11. The firm shows a Beta (market volatility) of 0.4554, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Amgen's beta means in this case. As returns on the market increase, Amgen returns are expected to increase less than the market. However, during the bear market, the loss on holding Amgen will be expected to be smaller as well. Although it is vital to follow Amgen Inc historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Amgen Inc technical indicators, you can presently evaluate if the expected return of 0.25% will be sustainable into the future. Please makes use of Amgen Inc treynor ratio, and the relationship between the standard deviation and downside variance to make a quick decision on whether Amgen price patterns will revert.
  
Amgen Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Amgen Inc are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent technical and fundamental indicators, Amgen disclosed solid returns over the last few months and may actually be approaching a breakup point. ...more

Structure and Payout Changes

Forward Dividend Yield
0.0272
Payout Ratio
0.4321
Last Split Factor
2:1
Forward Dividend Rate
7.76
Dividend Date
2022-12-08
Ex Dividend Date
2022-11-16

Amgen Price Channel

Begin Period Cash Flow6266000000.00
Total Cashflows From Investing Activities733000000.00

Amgen Relative Risk vs. Return Landscape

If you would invest  24,377  in Amgen Inc on September 8, 2022 and sell it today you would earn a total of  3,952  from holding Amgen Inc or generate 16.21% return on investment over 90 days. Amgen Inc is currently generating 0.2537% in daily expected returns and assumes 1.7504% risk (volatility on return distribution) over the 90 days horizon. In different words, 15% of stocks are less volatile than Amgen, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Amgen is expected to generate 1.15 times more return on investment than the market. However, the company is 1.15 times more volatile than its market benchmark. It trades about 0.14 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.03 per unit of risk.

Amgen Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Amgen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amgen Inc, and traders can use it to determine the average amount a Amgen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1449

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsAMGN
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 1.75
  actual daily
 
 15 %
of total potential
 
1515
Expected Return
 0.25
  actual daily
 
 4 %
of total potential
 
44
Risk-Adjusted Return
 0.14
  actual daily
 
 11 %
of total potential
 
1111
Based on monthly moving average Amgen is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amgen by adding it to a well-diversified portfolio.

About Amgen Performance

To evaluate Amgen Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Amgen generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Amgen Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Amgen Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Amgen's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment 18.54  16.48 
Return on Average Assets 9.50  8.91 
Return on Average Equity 73.16  78.94 
Return on Invested Capital 0.18  0.18 
Return on Sales 0.30  0.39 

Things to note about Amgen Inc

Checking the ongoing alerts about Amgen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amgen Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Amgen Alerts

Equity Alerts and Improvement Suggestions

Amgen Inc has a poor financial position based on the latest SEC disclosures
Over 79.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: The Most-Sold Guru Stocks of the 3rd Quarter - GuruFocus.com
Please continue to Trending Equities. Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Amgen Stock analysis

When running Amgen Inc price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.202
Market Capitalization
152 B
Quarterly Revenue Growth YOY
(0.008) 
Return On Assets
0.0993
Return On Equity
1.1516
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine Amgen value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.